Dr. Matthew Pierre Deek, MD

Dr. Deek practices at University Hospital in Newark, New Jersey, part of State of New Jersey.

Dr. Deek's NPI, 1083146435, was assigned on April 3, 2017. Dr. Deek graduated from Rutgers Robert Wood Johnson Medical School in 2016. Dr. Deek's New Jersey license number on file is 25MA11051100.

Dr. Deek's primary practice is University Hospital, at 150 Bergen St, Newark, NJ 07103 in Essex County. The practice phone is (973) 972-4300.

Dr. Deek's primary practice is University Hospital in Newark, New Jersey, part of State of New Jersey. Dr. Deek is also affiliated with Robert Wood Johnson University Hospital. The medical group on file is University Neuro-Ophthalmology Associates. Dmand AI also links Dr. Deek to 1 more hospital and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Deek practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Deek's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Deek is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Deek's licenses on file in 2 states: New Jersey and District of Columbia.

Dmand AI lists bone cancer radiation, brain cancer radiation, cancer radiation-upper GI, colorectal cancer radiation, head & neck cancer radiation, lung cancer radiation, pancreatic cancer radiation and prostate cancer radiation among the conditions Dr. Deek treats.

CMS data shows 1,754 Medicare services from Dr. Deek across 15 procedure codes in 2024, for 211 Medicare patients. Medicare paid $133,556 for them.

CMS counts 211 Medicare patients who saw Dr. Deek in 2024. The largest group is 65 to 74, with 99 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Deek's median patient age at 72, with 37% women.

In 2024, Dr. Deek wrote 67 Medicare Part D claims for 47 patients. 82% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $137 in total drug cost. In 2021, CMS named 11 claims across 1 drug.

Dr. Deek accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Deek as offering telehealth.

Dmand AI links 88 papers to Dr. Deek, published from 2010 to 2025. 2023 was the busiest year, with 15. The most frequent topics are Prostatic Neoplasms, Neoplasm Metastasis and Radiosurgery. Dr. Deek has published most often in Int J Radiat Oncol Biol Phys. Dr. Deek's most frequent co-authors are Phuoc T. Tran, MD, PhD, Salma K. Jabbour and Ryan Matthew Phillips, MD, PhD.

CMS Open Payments shows 3 general payments to Dr. Deek from 3 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Mevion_Medical_Systems_Inc paid the most, $41.

Dr. Deek graduated from Rutgers Robert Wood Johnson Medical School in 2016.

Dr. Deek is in network with 9 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.